PTGFR

Rituximab : Safety and efficacy of rituximab-based first line treatment of chronic GVHD SB202190 : MAPKs and NF‐κB‐mediated acrylamide‐induced neuropathy in rat striatum and human neuroblastoma cells SY5Y